JORGE LOPEZ JR. was named general counsel for Memorial Sloan Kettering Cancer Center, effective July 1. Lopez is a partner at the law firm of Akin Gump Strauss Hauer & Feld LLP. He will succeed Roger Parker, who held the role since 1998 and earlier this year announced his plan to retire after 41 years... […]
SADIK ESENER will direct the Center for Early Detection Research at Oregon Health and Science University's Knight Cancer Institute. Esener will also hold the Wendt Family Endowed Chair in Early Cancer Detection.
UC SAN FRANCISCO and Berkeley Lights Inc. formed a collaboration that gives UCSF researchers access to Berkeley Lights’ opto-nanofluidic biosystems, including single-cell genomic profiling of pre-annotated tissue samples, the development of precision diagnostics, and point-of-care therapies. Through the collaboration, UCSF researchers will study various cancer types to better understand the characterization and functionality of cell... […]
TUFTS MEDICAL CENTER and New England Cancer Specialists formed a clinical affiliation to expand patients’ access to care, clinical trials, and survivorship resources. NECS is the largest provider of cancer services in Maine, with nearly 45,000 patient visits in 2015 at locations in Scarborough, Brunswick and Kennebunk. Through the affiliation agreement, Tufts MC will be... […]
BAYLOR COLLEGE OF MEDICINE and Baylor Scott & White Health have entered into an agreement to expand biomedical research in North and Central Texas. The largest not-for-profit health care system in Texas, Baylor Scott & White Health was born from the 2013 merger of Baylor Health Care System and Scott & White Healthcare. A search... […]
JOAN MASSAGUÉ received the International Award for Cancer Research, presented by the Pezcoller Foundation and the American Association for Cancer Research.
VANTAGE ONCOLOGY LLC will be acquired by McKesson Specialty Health. Vantage is a provider of radiation oncology, medical oncology, and other integrated cancer care services. “We are excited about what Vantage can accomplish as part of the McKesson platform,” said Michael Fiore, chief executive officer and co-founder of Vantage. “By joining together, we will be... […]
IBM and the New York Genome Center will collaborate on a comprehensive and open repository of genetic data to accelerate cancer research, using Watson technology. The collaboration was announced at the White House’s Precision Medicine Initiative Summit. IBM and the center will build the capacity to house the contributed data, train Watson’s cognitive computing capabilities... […]
THE INTERNATIONAL CANCER GENOME CONSORTIUM authorized its 1,000th user, giving them access to the Consortium’s Controlled Access datasets. ICGC datasets that catalogue tumor-specific mutations are unrestricted and freely available to the scientific community. However, the consortium developed an authorization process to distribute clinical and inherited genetic data associated with unique individuals in order to minimize... […]
MICHAEL BUKOSKY was appointed chief operating officer of USMD Holdings Inc., and will oversee daily operations of therapeutic, diagnostic and centralized services, including hospital services, cancer treatment centers, clinical and pathology labs, imaging, human resources, contracting, revenue cycle, marketing and communications and IT. Bukosky will retain his position as president of USMD Physician Practice Management,... […]
